Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced enrollment of the first patients in its ...
The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Tailored ablation guided by AI better prevented atrial ...
Johnson & Johnson (NYSE:JNJ) has launched its VARIPULSE Pro pulsed field ablation system in Europe following CE Mark approval ...
We demonstrated a significant rise in CRP at a median of 49 days after AF ablation. Although the subsequent decline in CRP observed at second follow-up (a median of 179 days after ablation) was not ...
London, United Kingdom – 1 September 2024: Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the ...
Researchers found that people with atrial fibrillation had lower MRI-based glymphatic activity and poorer cognitive ...
PFA was noninferior to cryoablation for first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation. Tissue-selective energy delivery and short application times offer ...
CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...
Atrial fibrillation – irregular heartbeats caused by abnormal electrical signals from the heart’s upper chambers – is the most common cardiac rhythm disorder. If left untreated, atrial fibrillation ...
Pulmonary-vein isolation is an effective treatment for paroxysmal atrial fibrillation. Pulsed field ablation (PFA) is a nonthermal ablation method with few adverse effects beyond the myocardium. Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results